Webinars
Accelerating Manufacturing for Next Generation hiPSC-Based Clinical Therapies
Summary: During this session, we review progress in several areas of advanced development and their impact on readiness for large scale manufacturing.
View Now
Video
An Interview: Potential of iPSCs
Summary: In this informative interview with Phacilitate, Boris Greber and Thomas Marx answer questions about the position of induced pluripotent stem cells in today’s advanced therapies market and the transformative power latent in their clinical application.
View Now
eBook
Cellular Starting Materials In Focus
Summary: In this ebook, we bring you expert insights into the advantages that various cellular starting materials have, with a particular focus on human induced pluripotent stem cells (iPSCs).
View Now
Infographic
Features of iPSCs as Starting Materials
Summary: How can using iPSCs as starting materials help with transforming cell therapies into standard care? This infographic highlights the key features of iPSCs as starting materials, from donor consent through to commercial innovation.
View Now
Podcast
Manufacturing Cell Therapies with an Individualized Mindset
Summary: This podcast focuses on the specialized needs of manufacturing cell therapies at scale and how Custom Manufacturing Organizations are stepping in to drive process efficiencies and standardization.
View Now
Webinars
Strategies to Advance iPSC Therapies to Clinic
Summary: In this presentation, our Expert discusses efforts underway at Catalent to accelerate the path to clinic for iPSC-based therapies.
View Now
Webinars
Reengineering CAR-T for Solid Tumors
Summary: Scientists are leading a well-funded drive to adapt technology for solid tumors while making the whole process much more economical for patients and payers.
View Now
Webinars
Manufacturing Considerations for Mesenchymal Cells and Broader Allogeneic Modalities
Summary: At Catalent, we implement innovative manufacturing and fill & finish methodologies to accelerate the path to commercial for MSCs and other allogeneic modalities.
View Now
Webinars
Then and Now – Delivering a Successful Therapeutic to Patients
Summary: Experts discuss the changing experience from the last quarter of a century in the pathway to patients, and how the latest advanced technologies translate into effective pre-clinical and clinical development and manufacturing.
View Now
Webinars
Moving to Commercial Readiness with a Dedicated Analytical Platform for T-cell Therapies
Summary: Experts discuss a breadth of analytical methodologies, fill & finish approaches and manufacturing designs to accelerate CAR-T therapies to commercial readiness phase in this on-demand webinar.
View Now